Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sequence46 is a CAP-certified genetic testing laboratory specializing in preimplantation genetic testing (PGT) services including PGT-A, PGT-SR, and PGT-M. The company partners with leading fertility centers across North America to provide advanced reproductive genetics diagnostics aimed at improving IVF outcomes. Their offerings are commercially available and used by clinics to help increase pregnancy success rates and reduce the risk of inherited diseases in children. No clinical trial results are published; their work is based on established diagnostic protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sequence46.